:Each film coated tablet contains Rivaroxaban INN 2.5 mg
The medicine is indicated for the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardic biomarkers (Troponin or CK-MB). It is co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel or ticlopidine.
:Each film coated tablet contains Rivaroxaban INN 2.5 mg
The medicine is indicated for the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardic biomarkers (Troponin or CK-MB). It is co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel or ticlopidine.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.